Quotient Wealth Partners’s Biogen BIIB Stock Holding History

Quotient Wealth Partners’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$226K	Sell	1,047 -50	-5%	-$9.56K	0.01%	367
2026 Q1	$201K	Buy	+1,097	New	+$202K	0.01%	360
2024 Q4	–	Sell	-1,910	Closed	-$370K	–	326
2024 Q3	$370K	Sell	1,910 -719	-27%	-$150K	0.01%	214
2024 Q2	$609K	Sell	2,629 -5,164	-66%	-$1.12M	0.02%	153
2024 Q1	$1.68M	Sell	7,793 -5,520	-41%	-$1.29M	0.06%	85
2023 Q4	$3.45M	Buy	+13,313	New	+$3.27M	0.13%	70

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Quotient Wealth Partners's BIIB Position: Q2 2026 in Review

Quotient Wealth Partners reduced its Biogen (BIIB) stake by 4.6% in Q2 2026, selling an estimated $9.56K and leaving 1,047 shares worth $226K. The position accounts for 0.01% of the portfolio, ranked #367.

Quotient Wealth Partners first reported a position in BIIB in Q4 2023 and has held it in 6 quarters since. The position peaked at $3.45M in Q4 2023. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Quotient Wealth Partners held 1,047 shares of Biogen worth $226K as of Q2 2026.
Quotient Wealth Partners sold 50 Biogen shares in Q2 2026, an estimated $9.56K.
Biogen made up 0.01% of Quotient Wealth Partners's portfolio in Q2 2026, its #367 holding.
Quotient Wealth Partners first reported a position in Biogen in Q4 2023 and has held it in 6 quarters since.
Quotient Wealth Partners's Biogen position peaked at $3.45M in Q4 2023.
1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Quotient Wealth Partners's 13F filing for Q2 2026, filed 3 Aug 2026.